185 related articles for article (PubMed ID: 27492256)
1. Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators.
Qiu J; Zhou B; Thol F; Zhou Y; Chen L; Shao C; DeBoever C; Hou J; Li H; Chaturvedi A; Ganser A; Bejar R; Zhang DE; Fu XD; Heuser M
RNA; 2016 Oct; 22(10):1535-49. PubMed ID: 27492256
[TBL] [Abstract][Full Text] [Related]
2. Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures.
Jenkins JL; Kielkopf CL
Trends Genet; 2017 May; 33(5):336-348. PubMed ID: 28372848
[TBL] [Abstract][Full Text] [Related]
3. Accelerated DNA replication fork speed due to loss of R-loops in myelodysplastic syndromes with SF3B1 mutation.
Rombaut D; Lefèvre C; Rached T; Bondu S; Letessier A; Mangione RM; Farhat B; Lesieur-Pasquier A; Castillo-Guzman D; Boussaid I; Friedrich C; Tourville A; De Carvalho M; Levavasseur F; Leduc M; Le Gall M; Battault S; Temple M; Houy A; Bouscary D; Willems L; Park S; Raynaud S; Cluzeau T; Clappier E; Fenaux P; Adès L; Margueron R; Wassef M; Alsafadi S; Chapuis N; Kosmider O; Solary E; Constantinou A; Stern MH; Droin N; Palancade B; Miotto B; Chédin F; Fontenay M
Nat Commun; 2024 Apr; 15(1):3016. PubMed ID: 38589367
[TBL] [Abstract][Full Text] [Related]
4. Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations.
Lee SC; North K; Kim E; Jang E; Obeng E; Lu SX; Liu B; Inoue D; Yoshimi A; Ki M; Yeo M; Zhang XJ; Kim MK; Cho H; Chung YR; Taylor J; Durham BH; Kim YJ; Pastore A; Monette S; Palacino J; Seiler M; Buonamici S; Smith PG; Ebert BL; Bradley RK; Abdel-Wahab O
Cancer Cell; 2018 Aug; 34(2):225-241.e8. PubMed ID: 30107174
[TBL] [Abstract][Full Text] [Related]
5. Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes.
Dolatshad H; Pellagatti A; Liberante FG; Llorian M; Repapi E; Steeples V; Roy S; Scifo L; Armstrong RN; Shaw J; Yip BH; Killick S; Kušec R; Taylor S; Mills KI; Savage KI; Smith CW; Boultwood J
Leukemia; 2016 Dec; 30(12):2322-2331. PubMed ID: 27211273
[TBL] [Abstract][Full Text] [Related]
6. Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths.
Cortés-López M; Chamely P; Hawkins AG; Stanley RF; Swett AD; Ganesan S; Mouhieddine TH; Dai X; Kluegel L; Chen C; Batta K; Furer N; Vedula RS; Beaulaurier J; Drong AW; Hickey S; Dusaj N; Mullokandov G; Stasiw AM; Su J; Chaligné R; Juul S; Harrington E; Knowles DA; Potenski CJ; Wiseman DH; Tanay A; Shlush L; Lindsley RC; Ghobrial IM; Taylor J; Abdel-Wahab O; Gaiti F; Landau DA
Cell Stem Cell; 2023 Sep; 30(9):1262-1281.e8. PubMed ID: 37582363
[TBL] [Abstract][Full Text] [Related]
7. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.
Lee SC; Dvinge H; Kim E; Cho H; Micol JB; Chung YR; Durham BH; Yoshimi A; Kim YJ; Thomas M; Lobry C; Chen CW; Pastore A; Taylor J; Wang X; Krivtsov A; Armstrong SA; Palacino J; Buonamici S; Smith PG; Bradley RK; Abdel-Wahab O
Nat Med; 2016 Jun; 22(6):672-8. PubMed ID: 27135740
[TBL] [Abstract][Full Text] [Related]
8. Aberrant Alternative Splicing in U2af1/Tet2 Double Mutant Mice Contributes to Major Hematological Phenotypes.
Martínez-Valiente C; Garcia-Ruiz C; Rosón B; Liquori A; González-Romero E; Fernández-González R; Gómez-Redondo I; Cervera J; Gutiérrez-Adán A; Sanjuan-Pla A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203454
[TBL] [Abstract][Full Text] [Related]
9. Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies.
Biancon G; Joshi P; Zimmer JT; Hunck T; Gao Y; Lessard MD; Courchaine E; Barentine AES; Machyna M; Botti V; Qin A; Gbyli R; Patel A; Song Y; Kiefer L; Viero G; Neuenkirchen N; Lin H; Bewersdorf J; Simon MD; Neugebauer KM; Tebaldi T; Halene S
Mol Cell; 2022 Mar; 82(6):1107-1122.e7. PubMed ID: 35303483
[TBL] [Abstract][Full Text] [Related]
10. Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome.
Nagehan P; Sabbir M; Song J; Mohammad H
J Clin Exp Hematop; 2023; 63(3):173-176. PubMed ID: 37766563
[TBL] [Abstract][Full Text] [Related]
11. RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS.
Huang YJ; Chen JY; Yan M; Davis AG; Miyauchi S; Chen L; Hao Y; Katz S; Bejar R; Abdel-Wahab O; Fu XD; Zhang DE
Blood Adv; 2022 Dec; 6(23):6078-6092. PubMed ID: 36206200
[TBL] [Abstract][Full Text] [Related]
12. Predicting survival in patients with myelodysplastic/myeloproliferative neoplasms with SF3B1 mutation and thrombocytosis.
Li F; Qin T; Li B; Qu S; Pan L; Zhang P; Sun Q; Cai W; Gao Q; Jiao M; Li J; Ai X; Ma J; Gale RP; Xu Z; Xiao Z
Leukemia; 2024 Jun; 38(6):1334-1341. PubMed ID: 38714876
[TBL] [Abstract][Full Text] [Related]
13. Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1.
Trsova I; Hrustincova A; Krejcik Z; Kundrat D; Holoubek A; Staflova K; Janstova L; Vanikova S; Szikszai K; Klema J; Rysavy P; Belickova M; Kaisrlikova M; Vesela J; Cermak J; Jonasova A; Dostal J; Fric J; Musil J; Dostalova Merkerova M
Mol Oncol; 2023 Dec; 17(12):2565-2583. PubMed ID: 37408496
[TBL] [Abstract][Full Text] [Related]
14. Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring Sideroblasts.
Moura PL; Mortera-Blanco T; Hofman IJ; Todisco G; Kretzschmar WW; Björklund AC; Creignou M; Hagemann-Jensen M; Ziegenhain C; Cabrerizo Granados D; Barbosa I; Walldin G; Jansson M; Ashley N; Mead AJ; Lundin V; Dimitriou M; Yoshizato T; Woll PS; Ogawa S; Sandberg R; Jacobsen SEW; Hellström-Lindberg E
Cancer Res; 2024 Jan; 84(2):211-225. PubMed ID: 37921711
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxis.
Gurule NJ; Malcolm KC; Harris C; Knapp JR; O'Connor BP; McClendon J; Janssen WJ; Lee FFY; Price C; Osaghae-Nosa J; Wheeler EA; McMahon CM; Pietras EM; Pollyea DA; Alper S
Leukemia; 2023 Oct; 37(10):2115-2124. PubMed ID: 37591942
[TBL] [Abstract][Full Text] [Related]
16. SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing.
Komeno Y; Huang YJ; Qiu J; Lin L; Xu Y; Zhou Y; Chen L; Monterroza DD; Li H; DeKelver RC; Yan M; Fu XD; Zhang DE
Mol Cell Biol; 2015 Sep; 35(17):3071-82. PubMed ID: 26124281
[TBL] [Abstract][Full Text] [Related]
17. Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML.
Wheeler EC; Martin BJE; Doyle WC; Neaher S; Conway CA; Pitton CN; Gorelov RA; Donahue M; Jann JC; Abdel-Wahab O; Taylor J; Seiler M; Buonamici S; Pikman Y; Garcia JS; Belizaire R; Adelman K; Tothova Z
Sci Transl Med; 2024 Jan; 16(728):eade2774. PubMed ID: 38170787
[TBL] [Abstract][Full Text] [Related]
18. Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome.
Colla S; Ong DS; Ogoti Y; Marchesini M; Mistry NA; Clise-Dwyer K; Ang SA; Storti P; Viale A; Giuliani N; Ruisaard K; Ganan Gomez I; Bristow CA; Estecio M; Weksberg DC; Ho YW; Hu B; Genovese G; Pettazzoni P; Multani AS; Jiang S; Hua S; Ryan MC; Carugo A; Nezi L; Wei Y; Yang H; D'Anca M; Zhang L; Gaddis S; Gong T; Horner JW; Heffernan TP; Jones P; Cooper LJ; Liang H; Kantarjian H; Wang YA; Chin L; Bueso-Ramos C; Garcia-Manero G; DePinho RA
Cancer Cell; 2015 May; 27(5):644-57. PubMed ID: 25965571
[TBL] [Abstract][Full Text] [Related]
19. Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia.
Senapati J; Urrutia S; Loghavi S; Short NJ; Issa GC; Maiti A; Abbas HA; Daver NG; Pemmaraju N; Pierce S; Chien KS; Sasaki K; Kadia TM; Hammond DE; Borthakur G; Patel K; Ravandi F; Kantarjian HM; Garcia-Manero G; DiNardo CD
Blood; 2023 Nov; 142(19):1647-1657. PubMed ID: 37441846
[TBL] [Abstract][Full Text] [Related]
20. Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts.
Adema V; Ma F; Kanagal-Shamanna R; Thongon N; Montalban-Bravo G; Yang H; Peslak SA; Wang F; Acha P; Sole F; Lockyer P; Cassari M; Maciejewski JP; Visconte V; Gañán-Gómez I; Song Y; Bueso-Ramos C; Pellegrini M; Tan TM; Bejar R; Carew JS; Halene S; Santini V; Al-Atrash G; Clise-Dwyer K; Garcia-Manero G; Blobel GA; Colla S
Blood Cancer Discov; 2022 Nov; 3(6):554-567. PubMed ID: 35926182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
